AUTOANTIBODIES TO GLUTAMIC ACID DECARBOXYLASE AS A PATHOGENETIC MARKER OF TYPE I DIABETES MELLITUS
Abstract. A new method of enzyme-linked immunosorbent assay (in solid-phase ELISA format) has been developed to determine concentrations of autoantibodies to glutamic acid decarboxylase, as well as an evidencebased methodology is proposed for its medical implications, as a quantitative pathogenetic...
Saved in:
Main Authors: | N. V. Piven, L. N. Lukhverchyk, A. I. Burakovsky, N. V. Polegenkaya, M. V. Karpovich |
---|---|
Format: | article |
Language: | RU |
Published: |
SPb RAACI
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/06cf4f3946f64cc3b21d9c52a17c2f71 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic value of islet autoantibody assays practised in Russia. 1. Classic immunofluorescence islet cell antibody assay, immunoradiometric glutamic acid decarboxylase antibody assay, and ELISA tyrosine phosphatase antibody and insulin antibody assays
by: Alexei V. Timofeev, et al.
Published: (2016) -
PATHOGENETIC ROLE OF ABZYME-TYPE AUTOANTIBODIES IN THE ORGAN-SPECIFIC AUTOIMMUNE PATHOLOGY
by: L. N. Luchverchyk, et al.
Published: (2014) -
Antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study
by: Mendivil CO, et al.
Published: (2017) -
Differential diagnostic utilities of combined testing for islet cell antibody, glutamic acid decarboxylase antibody, and tyrosine phosphatase antibody
by: Alexei V. Timofeev, et al.
Published: (2018) -
Typical case of LADA
by: A A Krivko, et al.
Published: (2009)